Autres langues MINAPHARM Pharmaceuticals

Actions

MIPH

EGS380G1C011

Produits pharmaceutiques

Cours en clôture Egyptian Exchange 01/10/2026			Varia. 5j.	Varia. 1 janv.
812,49 ^EGP	+4,21%		+0,32%	+132,67%

27/08	La CEPI soutient le vaccin expérimental de Minapharm contre Ebola avec un financement allant jusqu'à 16,5 millions de dollars	RE
27/08	Le groupe Minapharm reçoit un financement pour faire progresser son candidat-vaccin contre le virus Ebola Bundibugyo vers les essais cliniques	CI

Autres langues

27/08	CEPI backs Minapharm's experimental Ebola vaccine with up to $16.5 million funding
27/08	Minapharm Group Receives Funding to Advance Bundibugyo Ebolavirus Vaccine Candidate to Clinical Trials
17/08	MINAPHARM Pharmaceuticals Reports Earnings Results for the First Quarter Ended March 31, 2026
10/06	MINAPHARM Pharmaceuticals Reports Earnings Results for the Full Year Ended December 31, 2025
05/05	Minapharm pharmaceuticals FY standalone net profit EGP 57.5 million
30/11	Minapharm Pharmaceuticals Q3 consol profit egp 16.8 million
30/11	MINAPHARM Pharmaceuticals Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
14/09/25	MINAPHARM Pharmaceuticals Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
14/09/25	Minapharm Pharmaceuticals Q2 consol profit EGP 40 million
27/07/25	MINAPHARM Pharmaceuticals Reports Earnings Results for the First Quarter Ended March 31, 2025
27/07/25	Minapharm Pharmaceuticals Q1 consol net loss EGP 2 million
07/07/25	EBRD, Admaius Capital plan to acquire 15%-20% of Egyptian Minapharm Pharmaceuticals
12/06/25	MINAPHARM Pharmaceuticals Reports Earnings Results for the Full Year Ended December 31, 2024
12/06/25	Minapharm Pharmaceuticals FY Colsol Net Profit EGP 161.1 Million
26/05/25	Minapharm Pharmaceuticals FY Standalone Profit EGP 162.8 Million
26/03/25	African Development Bank Approves Eur 15 Million Loan to Boost Biosimilars' Development and Production in Egypt
03/12/24	MINAPHARM Pharmaceuticals Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024
01/09/24	MINAPHARM Pharmaceuticals Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
30/05/24	MINAPHARM Pharmaceuticals Reports Earnings Results for the First Quarter Ended March 31, 2024
07/04/24	MINAPHARM Pharmaceuticals Reports Earnings Results for the Full Year Ended December 31, 2023
05/10/23	SaudiVax, Minapharm, and MiGenTra Sign a Memorandum of Understanding towards a Strategic Partnership in Saudi Arabia and the Gulf Cooperation Countries
04/10/23	SaudiVax, Minapharm, and MiGenTra Sign a Memorandum of Understanding towards a Strategic Partnership in Saudi Arabia and the Gulf Cooperation Countries This landmark MOU marks a significant step towards ensuring national health security and achieving biomanufacturing autonomy in Saudi Arabia
29/08/23	MINAPHARM Pharmaceuticals Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
29/05/23	MINAPHARM Pharmaceuticals Reports Earnings Results for the First Quarter Ended March 31, 2023
30/03/23	MINAPHARM Pharmaceuticals Reports Earnings Results for the Full Year Ended December 31, 2022